Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
HAMILTON THORNE Aktie jetzt für 0€ handeln | |||||
02.12.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.12.2024 | 355 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 02.12.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.12.2024ISIN NameCA81012R1064 SCOTTIE... ► Artikel lesen | |
02.12.24 | Astorg Completes Take Private of Hamilton Thorne and Concurrent Acquisition of Cook Medical Reproductive Health | 323 | Business Wire | Establishing a Global Leader in Assisted Reproductive Technology Consumables and Equipment
Hamilton Thorne delists from the Toronto Stock Exchange Cook Medical Reproductive Health ("Cook... ► Artikel lesen | |
30.11.24 | Hamilton Thorne Ltd: Hamilton Thorne to be delisted from TSX Dec. 2 | 9 | Stockwatch | ||
29.11.24 | Hamilton Thorne Ltd: Hamilton Thorne closes going private deal | 1 | Stockwatch | ||
29.11.24 | Hamilton Thorne Ltd.: Hamilton Thorne Announces Closing of Going Private Transaction | 563 | Newsfile | Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - November 29, 2024) - Hamilton Thorne Ltd (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments... ► Artikel lesen | |
14.11.24 | Hamilton Thorne GAAP EPS of -$0.01, revenue of $19.38M beats by $0.09M | 1 | Seeking Alpha | ||
14.11.24 | Hamilton Thorne Ltd.: Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2024 | 223 | Newsfile | Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables,... ► Artikel lesen | |
17.10.24 | Hamilton Thorne Ltd: Hamilton Thorne receives court OK for go-private deal | 3 | Stockwatch | ||
17.10.24 | Hamilton Thorne Ltd.: Hamilton Thorne Provides Update on Going Private Transaction | 302 | Newsfile | Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - October 17, 2024) - Hamilton Thorne Ltd (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments,... ► Artikel lesen | |
17.09.24 | Hamilton Thorne Ltd.: Hamilton Thorne Announces Shareholder Approval of Going Private Transaction | 524 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software... ► Artikel lesen | |
14.08.24 | Hamilton Thorne Ltd.: Hamilton Thorne Reports Revenue for the Quarter and Six Months Ended June 30, 2024, and Confirms Annual Guidance | 174 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software, and services... ► Artikel lesen | |
22.07.24 | Hamilton Thorne Ltd.: Hamilton Thorne Announces Agreement to be Acquired by Astorg for CAD$2.25 Per Share in Cash | 258 | GlobeNewswire (Europe) | Purchase price of CAD$2.25 per Hamilton Thorne share represents enterprise value of approximately CAD$388 million (US$282 million).Represents a premium of approximately 54% to the closing price on... ► Artikel lesen | |
11.06.24 | Hamilton Thorne Ltd.: Hamilton Thorne Announces Voting Results of 2024 Annual Meeting | 169 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, June 11, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software... ► Artikel lesen | |
10.04.24 | Bloom Burton & Co. Inc.: Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference | 358 | Newsfile | Beverly, Massachusetts--(Newsfile Corp. - April 10, 2024) - Hamilton Thorne Ltd. (TSX: HTL) (OTC Pink: HTLZF), Hamilton Thorne Ltd. a leading provider of precision instruments, laboratory equipment... ► Artikel lesen | |
27.03.24 | Hamilton Thorne Ltd.: Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023 | 191 | GlobeNewswire (Europe) | BEVERLY, Mass. and TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 84,62 | +0,44 % | Research and Markets: Europe Implantable Loop Recorders Market Analysis and Forecast, 2025-2035 with Medtronic, Abbott Laboratories, Boston Scientific, and BIOTRONIK Leading - ResearchAndMarkets.com | The "Europe Implantable Loop Recorders Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.
Key players in the market are Medtronic PLC., Abbott... ► Artikel lesen | |
INTUITIVE SURGICAL | 446,85 | +1,23 % | Intuitive Surgical Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
UNITEDHEALTH | 463,00 | +0,83 % | Opening Bell: United Health, Starbucks, Alphabet, Intel, Affirm Holdings, Ferrari | Schwache US-Konjunkturdaten sorgten für positive Impulse an den Märkten. Dies reduzierte Inflationssorgen und weckte Hoffnungen auf stabile oder sinkende Zinsen. Der Dow Jones gewann 0,85 Prozent hinzu... ► Artikel lesen | |
TELADOC HEALTH | 7,749 | +0,77 % | Teladoc Health Q1 Preview: Analyst Says Strategic Direction Is Good, But There's 'More Work To Be Done' | ||
SERNOVA BIOTHERAPEUTICS | 0,115 | -2,70 % | Sernova Aktie: Positives Umsatzwachstum gemeldet! | Das Biotechnologieunternehmen erweitert sein Führungsteam, sichert Finanzierungen und erhält FDA-Freigabe für klinische Studien zur Behandlung von Hypothyreose. Sernova Biotherapeutics, ehemals Sernova... ► Artikel lesen | |
SYNLAB | 11,500 | -0,86 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
HCA HEALTHCARE | 303,00 | +0,40 % | Dividendenbekanntmachungen (17.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALTAGAS LTD CA0213611001 0,315 CAD 0,2014 EUR AMERICAN FINANCIAL GROUP INC US0259321042 2 USD 1,8382 EUR AMERICAN INTERNATIONAL... ► Artikel lesen | |
AMEDISYS | 83,50 | 0,00 % | Amedisys, Inc.: Amedisys Reports Fourth Quarter and Year End 2024 Financial Results | BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods... ► Artikel lesen | |
LANTHEUS | 93,30 | -0,13 % | AKTIONÄR-Tipp Lantheus: Telix-Rivale geht nach Zahlen durch die Decke | Der Radiopharma-Spezialist Lantheus kann am Donnerstag mit den Zahlen zum vierten Quartal respektive Gesamtjahr 2024 und dem Ausblick auf das laufende Jahr 2025 überzeugen. Die Aktie des Wettbewerbers... ► Artikel lesen | |
ENVISTA | 15,300 | -0,65 % | Envista: DEXIS Showcases Newest Technology at Chicago Midwinter and Lab Day Conferences | The global leader in dental imaging technologies will showcase the latest innovations added to its digital ecosystem - a suite of tools and software designed to connect the entire digital workflow from... ► Artikel lesen | |
CAREDX | 17,010 | -0,53 % | CareDx, Inc.: CareDx gibt Studie bekannt, die zeigt, dass AlloSeq cfDNA bei der Erkennung von Abstoßungsreaktionen bei Organtransplantationspatienten äußerst genau ist | AlloSeq cfDNA entspricht der Leistung des bewährten AlloSure-Tests CareDx bringt mit AlloSeq cfDNA ein innovatives nicht-invasives Transplantationsmonitoring für Patienten auf internationaler... ► Artikel lesen | |
SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal Second Quarter 2025 Results | Reports 23 Percent Increase in ARR to $19.1 Million and 61 Net New Platform Deployments HENDERSON, Nev., Feb. 13, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading... ► Artikel lesen | |
GT BIOPHARMA | 2,430 | 0,00 % | GT Biopharma, Inc.: GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit | ||
CARMAT | 0,868 | -1,36 % | CARMAT: Aeson total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation | Up to 25% of advanced heart failure patients suffer from pulmonary hypertension
Aeson® could potentially become a standard treatment for these thousands of patients, both as a bridge-to-transplant... ► Artikel lesen |